Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Laughing Water Capital's investment thesis on AnaptysBio Inc ($ANAB) — Q2 2026 | Buyside Digest

All Pitches

View Letter Analysis

$ANABNASDAQAnaptysBio Inc

NEUTRAL

Laughing Water Capital—ANAB

Fund Letter

Q2 2026

Published July 17, 2026

View Fund Profile

$58.37USD

+2.8% vs last month

$54.15Pitched

+7.8% since pitch

Market Cap$1.6B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Laughing Water Capital returned 39.8% net in Q2 2026, bringing year-to-date returns to 33.6% and 10-year annualized returns to 20.0%. The exceptional quarter...

— Matthew Sweeney

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $ANAB, and what else Laughing Water Capital is buying.

Other pitches on $ANAB

Other investors who've written on AnaptysBio Inc

Triples InvestingBULL

Pitched Jun 15, 2026•Pitched at $59.51

Operating with extremely low overhead of less than $10 million annually and under ten contract staff, the company features high-margin operations and active share repurchases. Jemperli's sales continue...

View all $ANAB pitches →